Clinical Trial Update: Early-phase Study of ART002g1 Injection in HeFH: Safety, Tolerability and Preliminary Efficacy [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase (Phase 1) study of ART002g1 injection for heterozygous familial hypercholesterolemia, focusing on safety, tolerability, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia

Drugs mentioned

• ART002g1

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Heterozygous Familial Hypercholesterolemia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING